Periodic Reporting for period 2 - MetaTox-HS (Advanced Solutions for High Sensitivity Metabolism and Toxicity Assays)
Reporting period: 2018-06-01 to 2019-05-31
WP2: dOxyCheck: Requirement specifications captured, sensors optimised for sample and reference measurement. Prototype instruments successfully measuring sensors and delivering analyte concentrations.
WP3: Demonstration: Solution demonstration and initial utility assessment complete for cell respiration measurements. Solution demonstration also initiated for dOxyCheck.
WP4: Training & Dissemination: Commercialisation Plan developed, initial inputs assimilated from WP3 in preparation for materials development and related dissemination. Early KOL engagement underway.
WP5: Business Solution Exploitation: Commercial Partner Agreements established. Sales channel preparation underway
WP6: Project Management: Composite PMP developed, Resources managed through new hires and restructuring of project organisational structure. Regular structured interaction between sub-contract partners and early adopters as per Communications Plan.
Significant progress has also been made in sensor development, and instrumentation productisation, whereby novel optical sensors have been developed and are currently being upscaled, and intuitive measurements solution are at a late prototyping stage prior to first end-user engagement. This is a significant advance on the state of the art, particularly with regard to sensor design and flexible sensor deployment. It is expected that a the fully functional enabling measurement solution (sensors and instrument) will be developed, demonstrated and deployed prior to project end.